US 7816372
6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
granted A61PA61P13/08A61P15/00
Quick answer
US patent 7816372 (6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61P, A61P13/08, A61P15/00, A61P15/10, A61P17/00